沃尔玛将于1月20日取代阿斯利康纳入纳斯达克100指数，盘前股价上涨2.6%。

Group 1 - Walmart will replace AstraZeneca in the Nasdaq 100 index on January 20, leading to a pre-market stock price increase of 2.6% [1]